부산대학교 도서관

Sorror ML; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Gooley TA; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.; Storer BE; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.; Gerds AT; Leukemia & Myeloid Disorders Program, Cleveland Clinic, Cleveland, OH.; Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Medeiros BC; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.; Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Shami PJ; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.; Adekola K; Division of Hematology Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.; Luger S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.; Wildes TM; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha NE.; Koprivnikar J; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.; Smith J; Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA.; Garrison M; Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA.; Kojouri K; Skagit Valley Hospital, Mount Vernon, WA.; Schuler TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Leisenring WM; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.; Onstad LE; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Becker PS; Division of Hematology/Oncology, University of California, Irvine, Irvine, CA.; Department of Population Sciences, City of Hope, Duarte, CA.; McCune JS; Division of Hematology/Oncology, University of California, Irvine, Irvine, CA.; Department of Population Sciences, City of Hope, Duarte, CA.; Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Estey EH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Davis JA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Rizzieri DA; Duke Cancer Institute, Durham, NC, USA.; Lane AA; Medical Oncology, Dana Farber - Harvard Institute, Boston, MA, USA.; Taylor J; University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Faisal MS; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Vasu S; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Soong D; University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Li H; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Herbst A; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Greenwell IB; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, TX.; Sweet KL; H. Lee Moffitt Cancer Center, Tampa, FL.; Stein AS; City of Hope National Medical Center, Duarte, CA.; Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Rizzieri DA; Duke University Medical Center, Durham, NC.; Vasu S; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Rosenblat TL; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.; Brooks CL; Stemline Therapeutics, New York, NY.; Habboubi N; Stemline Therapeutics, New York, NY.; Mughal TI; Stemline Therapeutics, New York, NY.; Tufts University School of Medicine, Boston, MA.; Kantarjian H; The University of Texas MD Anderson Cancer Center, Houston, TX.; Konopleva M; The University of Texas MD Anderson Cancer Center, Houston, TX.; Lane AA; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.; DiNardo CD; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.; Pigneux A; Department of Hematology, CHU de Bordeaux, Bordeaux, France.; Fiedler W; Department of Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Konopleva M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rizzieri DA; Novant Health Cancer Institute, Charlotte, Durham, North Carolina.; Smith BD; Department of Oncology, Johns Hopkins Medicine, Baltimore, Maryland.; Shinagawa A; Department of Hematology, Hitachi General Hospital, Hitachi-shi, Japan.; Lemoli RM; Clinic of Hematology, Department of Internal Medicine, University of Genoa, Genoa, Italy.; San Martino Hospital IRCCS, Genoa, Italy.; Dail M; Genentech Inc., South San Francisco, California.; Duan Y; AbbVie Inc., North Chicago, Illinois.; Chyla B; AbbVie Inc., North Chicago, Illinois.; Potluri J; AbbVie Inc., North Chicago, Illinois.; Miller CL; AbbVie Inc., North Chicago, Illinois.; Kantarjian HM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Xie A; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Vaganay C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Benaksas C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Ling F; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Sodaro G; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Meslin PA; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Fenouille N; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Hoj J; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Washart R; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Ang HX; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Chaintreuil P; Université Côte d'Azur, Nice, France.; Jacquel A; Université Côte d'Azur, Nice, France.; Auberger P; Université Côte d'Azur, Nice, France.; Forget A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Itzykson R; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Lu M; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.; Lin J; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Pierobon M; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA.; Sheng Z; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Li X; Department of Biomedical Engineering, Duke University, Durham, NC, USA.; Chilkoti A; Department of Biomedical Engineering, Duke University, Durham, NC, USA.; Owzar K; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, USA.; Benajiba L; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France.; Petricoin E; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA.; Puissant A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France. alexandre.puissant@inserm.fr.; Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Albert DH; AbbVie, Inc., North Chicago, IL, U.S.A.; daniel.h.albert@abbvie.com.; Goodwin NC; Champions Oncology, Inc., Hackensack, NJ, U.S.A.; Davies AM; Champions Oncology, Inc., Hackensack, NJ, U.S.A.; Rowe J; HuMurine Technologies, La Verne, CA, U.S.A.; Feuer G; HuMurine Technologies, La Verne, CA, U.S.A.; Boyiadzis M; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, U.S.A.; Dorritie KA; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, U.S.A.; Mancini M; Champions Oncology, Inc., Hackensack, NJ, U.S.A.; Gandour-Edwards R; Department of Pathology & Laboratory Medicine, UC Davis School of Medicine, Sacramento, CA, U.S.A.; Jonas BA; University of California Davis School of Medicine, Sacramento, CA, U.S.A.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson, Houston, TX, U.S.A.; Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, U.S.A.; Rizzieri DA; Medical Oncology, Novant Health Cancer Institute, Charlotte, NC, U.S.A.; Odenike O; Section of Hematology/Oncology, The University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, U.S.A.; Prebet T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, U.S.A.; Singh S; AbbVie, Inc., North Chicago, IL, U.S.A.; Popovic R; AbbVie, Inc., North Chicago, IL, U.S.A.; Shen YU; AbbVie, Inc., North Chicago, IL, U.S.A.; McDaniel KF; AbbVie, Inc., North Chicago, IL, U.S.A.; Kati WM; AbbVie, Inc., North Chicago, IL, U.S.A.; Modi DA; AbbVie, Inc., North Chicago, IL, U.S.A.; Motwani M; AbbVie, Inc., North Chicago, IL, U.S.A.; Wolff JE; AbbVie, Inc., North Chicago, IL, U.S.A.; Frost DJ; AbbVie, Inc., North Chicago, IL, U.S.A.

Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

Spasojevic I; da Costa LR; Horwitz ME; Long GD; Sullivan KM; Chute JP; Gasparetto C; Morris A; Chao NJ; Rizzieri DA; Spasojevic, Ivan; da Costa, Ligia R S; Horwitz, Mitchell E; Long, Gwynn D; Sullivan, Keith M; Chute, John P; Gasparetto, Cristina; Morris, Ashley; Chao, Nelson J; Rizzieri, David A

Cancer Investigation. Nov2012, Vol. 30 Issue 9, p679-682. 4p.

Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B

Journal of Clinical Oncology; 11/20/2009, Vol. 27 Issue 33, p5580-5586, 7p

Laughlin MJ; Barker J; Bambach B; Koc ON; Rizzieri DA; Wagner JE; Gerson SL; Lazarus HM; Cairo M; Stevens CE; Rubinstein P; Kurtzberg J

New England Journal of Medicine. 06/14/2001, Vol. 344 Issue 24, p1815-1822. 8p.

Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Begna KH; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Altman JK; Department of Medicine, Northwestern University, Chicago, Illinois.; Goldberg SL; Hackensack University Medical Center, Hackensack, New Jersey.; Sekeres MA; Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, Ohio.; Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Arellano ML; Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia.; Claxton DF; Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.; Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.; Gautier M; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.; Berman E; Memorial Sloan Kettering Cancer Center, New York, New York.; Seiter K; Department of Medicine, New York Medical College, Valhalla, New York.; Solomon SR; Northside Hospital Cancer Institute, Leukemia Program, Atlanta, Georgia.; Schiller GJ; Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine at the University of California, Los Angeles, California.; Luger SM; Department of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Butrym A; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.; Gaidano G; Division of Hematology, Maggiore della Carita University Hospital, Novara, Italy.; Thomas XG; Hematology, South Hospital Center, Lyon, France.; Montesinos P; La Fe University and Polytechnic Hospital, Valencia, Spain.; Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Quick DP; Joe Arrington Cancer Center, Lubbock, Texas.; Venugopal P; Department of Medicine, Hematology, and Oncology, Rush University Medical Center, Chicago, Illinois.; Gaur R; St Luke's Cancer Institute, Kansas City, Missouri.; Maness LJ; Division of Hematology-Oncology Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.; Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Buyse ME; International Drug Development Institute, Louvain-la-Neuve, Belgium.; Chiao JH; Cyclacel Limited, Dundee, United Kingdom.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE